Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments

Nontuberculous mycobacterial pulmonary disease (NTM-PD) remains a challenging condition to diagnose and treat effectively. Treatment of NTM-PD is prolonged, frequently associated with adverse effects and has variable success. In this review, we consider the factors influencing clinicians when treati...

Full description

Bibliographic Details
Main Authors: Kartik Kumar, Charles L. Daley, David E. Griffith, Michael R. Loebinger
Format: Article
Language:English
Published: European Respiratory Society 2022-02-01
Series:European Respiratory Review
Online Access:http://err.ersjournals.com/content/31/163/210212.full
_version_ 1818364608378830848
author Kartik Kumar
Charles L. Daley
David E. Griffith
Michael R. Loebinger
author_facet Kartik Kumar
Charles L. Daley
David E. Griffith
Michael R. Loebinger
author_sort Kartik Kumar
collection DOAJ
description Nontuberculous mycobacterial pulmonary disease (NTM-PD) remains a challenging condition to diagnose and treat effectively. Treatment of NTM-PD is prolonged, frequently associated with adverse effects and has variable success. In this review, we consider the factors influencing clinicians when treating NTM-PD and discuss outcomes from key studies on the pharmacological management of Mycobacterium avium complex pulmonary disease and M. abscessus pulmonary disease. We highlight issues relating to treatment-related toxicity and provide an overview of repurposed and emerging therapies for NTM-PD.
first_indexed 2024-12-13T22:07:04Z
format Article
id doaj.art-122af0c2ad194141bd3fe14bc292097a
institution Directory Open Access Journal
issn 0905-9180
1600-0617
language English
last_indexed 2024-12-13T22:07:04Z
publishDate 2022-02-01
publisher European Respiratory Society
record_format Article
series European Respiratory Review
spelling doaj.art-122af0c2ad194141bd3fe14bc292097a2022-12-21T23:29:49ZengEuropean Respiratory SocietyEuropean Respiratory Review0905-91801600-06172022-02-013116310.1183/16000617.0212-20210212-2021Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatmentsKartik Kumar0Charles L. Daley1David E. Griffith2Michael R. Loebinger3 National Heart and Lung Institute, Imperial College London, London, UK Division of Mycobacterial and Respiratory Infections, Dept of Medicine, National Jewish Health, Denver, CO, USA Division of Mycobacterial and Respiratory Infections, Dept of Medicine, National Jewish Health, Denver, CO, USA National Heart and Lung Institute, Imperial College London, London, UK Nontuberculous mycobacterial pulmonary disease (NTM-PD) remains a challenging condition to diagnose and treat effectively. Treatment of NTM-PD is prolonged, frequently associated with adverse effects and has variable success. In this review, we consider the factors influencing clinicians when treating NTM-PD and discuss outcomes from key studies on the pharmacological management of Mycobacterium avium complex pulmonary disease and M. abscessus pulmonary disease. We highlight issues relating to treatment-related toxicity and provide an overview of repurposed and emerging therapies for NTM-PD.http://err.ersjournals.com/content/31/163/210212.full
spellingShingle Kartik Kumar
Charles L. Daley
David E. Griffith
Michael R. Loebinger
Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments
European Respiratory Review
title Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments
title_full Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments
title_fullStr Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments
title_full_unstemmed Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments
title_short Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments
title_sort management of mycobacterium avium complex and mycobacterium abscessus pulmonary disease therapeutic advances and emerging treatments
url http://err.ersjournals.com/content/31/163/210212.full
work_keys_str_mv AT kartikkumar managementofmycobacteriumaviumcomplexandmycobacteriumabscessuspulmonarydiseasetherapeuticadvancesandemergingtreatments
AT charlesldaley managementofmycobacteriumaviumcomplexandmycobacteriumabscessuspulmonarydiseasetherapeuticadvancesandemergingtreatments
AT davidegriffith managementofmycobacteriumaviumcomplexandmycobacteriumabscessuspulmonarydiseasetherapeuticadvancesandemergingtreatments
AT michaelrloebinger managementofmycobacteriumaviumcomplexandmycobacteriumabscessuspulmonarydiseasetherapeuticadvancesandemergingtreatments